Literature DB >> 28377274

DynaMiTES - A dynamic cell culture platform for in vitro drug testing PART 2 - Ocular DynaMiTES for drug absorption studies of the anterior eye.

Nicole Beiβner1, Kai Mattern2, Andreas Dietzel2, Stephan Reichl3.   

Abstract

In the present study, a formerly designed Dynamic Micro Tissue Engineering System (DynaMiTES) was applied with our prevalidated human hemicornea (HC) construct to obtain a test platform for improved absorption studies of the anterior eye (Ocular DynaMiTES). First, the cultivation procedure of the classic HC was slightly adapted to the novel DynaMiTES design. The obtained inverted HC was then compared to classic HC regarding cell morphology using light and scanning electron microscopy, cell viability using MTT dye reaction and epithelial barrier properties observing transepithelial electrical resistance and apparent permeation coefficient of sodium fluorescein. These tested cell criteria were similar. In addition, the effects of four different flow rates on the same cell characteristics were investigated using the DynaMiTES. Because no harmful potential of flow was found, dynamic absorption studies of sodium fluorescein with and without 0.005%, 0.01% and 0.02% benzalkonium chloride were performed compared to the common static test procedure. In this proof-of-concept study, the dynamic test conditions showed different results than the static test conditions with a better prediction of in vivo data. Thus, we propose that our DynaMiTES platform provides great opportunities for the improvement of common in vitro drug testing procedures.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Benzalkonium chloride; DynaMiTES; Dynamic flow system; Human hemicornea construct; In vitro drug absorption; Microfluidic system; Organ on chip; TEER measurement

Mesh:

Substances:

Year:  2017        PMID: 28377274     DOI: 10.1016/j.ejpb.2017.03.021

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  8 in total

1.  New Classes of Polycationic Compounds as Preservatives for Ophthalmic Formulations.

Authors:  Dörte von Deylen; Christina Dreher; Oliver Seidelmann; Stephan Reichl
Journal:  Pharm Res       Date:  2018-11-08       Impact factor: 4.200

2.  In-Line Analysis of Organ-on-Chip Systems with Sensors: Integration, Fabrication, Challenges, and Potential.

Authors:  Stefanie Fuchs; Sofia Johansson; Anders Ø Tjell; Gabriel Werr; Torsten Mayr; Maria Tenje
Journal:  ACS Biomater Sci Eng       Date:  2021-06-16

Review 3.  Role of In Vitro Models for Development of Ophthalmic Delivery Systems.

Authors:  Shallu Kutlehria; Mandip Singh Sachdeva
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2021       Impact factor: 4.889

4.  Skin-on-a-Chip Device for Ex Vivo Monitoring of Transdermal Delivery of Drugs-Design, Fabrication, and Testing.

Authors:  Bence Lukács; Ágnes Bajza; Dorottya Kocsis; Attila Csorba; István Antal; Kristóf Iván; András József Laki; Franciska Erdő
Journal:  Pharmaceutics       Date:  2019-09-02       Impact factor: 6.321

5.  Tissue Barrier-on-Chip: A Technology for Reproducible Practice in Drug Testing.

Authors:  Eugen V Koch; Verena Ledwig; Sebastian Bendas; Stephan Reichl; Andreas Dietzel
Journal:  Pharmaceutics       Date:  2022-07-12       Impact factor: 6.525

Review 6.  Biomechanical analysis of ocular diseases and its in vitro study methods.

Authors:  Yali Zhao; Guohuang Hu; Yuwei Yan; Zhen Wang; Xiaohua Liu; Huanhuan Shi
Journal:  Biomed Eng Online       Date:  2022-07-23       Impact factor: 3.903

Review 7.  Looking into the Eyes-In Vitro Models for Ocular Research.

Authors:  Krystyna Lieto; Rafał Skopek; Aneta Lewicka; Marta Stelmasiak; Emilia Klimaszewska; Arthur Zelent; Łukasz Szymański; Sławomir Lewicki
Journal:  Int J Mol Sci       Date:  2022-08-15       Impact factor: 6.208

8.  Microfluidic System for In Vivo-Like Drug Permeation Studies with Dynamic Dilution Profiles.

Authors:  Thomas Lorenz; Mona Kirschke; Verena Ledwig; Stephan Reichl; Andreas Dietzel
Journal:  Bioengineering (Basel)       Date:  2021-05-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.